Shawn Singh
CHIEF EXECUTIVE OFFICER at Vistagen Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Vistagen Therapeutics Inc., 3 years.
Vistagen Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Vistagen Therapeutics Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 28, 2024 | Vistagen Therapeutics Inc. | Grant or award | +4,854 | $2.96 | $14,368 |
| Dec 29, 2023 | Vistagen Therapeutics Inc. | Grant or award | +167 | $1.72 | $287 |
| Jun 30, 2023 | Vistagen Therapeutics Inc. | Grant or award | +167 | $1.59 | $266 |
| Dec 30, 2022 | Vistagen Therapeutics Inc. | Grant or award | +5,000 | $0.09 | $450 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.